Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
2.
Clin Epigenetics ; 14(1): 94, 2022 07 23.
Article in English | MEDLINE | ID: covidwho-1957069

ABSTRACT

We recently reported the COVID-19-induced circulating leukocytes DNA methylation profile. Here, we hypothesized that some of these genes would persist differentially methylated after disease resolution. Fifteen participants previously hospitalized for SARS-CoV-2 infection were epityped one year after discharge. Of the 1505 acute illness-induced differentially methylated regions (DMRs) previously identified, we found 71 regions with persisted differentially methylated, with an average of 7 serial CpG positions per DMR. Sixty-four DMRs persisted hypermethylated, and 7 DMR persisted hypomethylated. These data are the first reported evidence that DNA methylation changes in circulating leukocytes endure long after recovery from acute illness.


Subject(s)
COVID-19 , DNA Methylation , Acute Disease , COVID-19/genetics , CpG Islands , Humans , SARS-CoV-2
3.
Respir Med ; 184: 106464, 2021 08.
Article in English | MEDLINE | ID: covidwho-1230753

ABSTRACT

BACKGROUND: The clinical features and outcomes of mechanically ventilated patients with COVID-19 infection who develop a pneumothorax has not been rigorously described or compared to those who do not develop a pneumothorax. PURPOSE: To determine the incidence, clinical characteristics, and outcomes of critically ill patients with COVID-19 infection who developed pneumothorax. In addition, we compared the clinical characteristics and outcomes of mechanically ventilated patients who developed a pneumothorax with those who did not develop a pneumothorax. METHODS: This study was a multicenter retrospective analysis of all adult critically ill patients with COVID-19 infection who were admitted to intensive care units in 4 tertiary care centers in the United States. RESULTS: A total of 842 critically ill patients with COVID-19 infection were analyzed, out of which 594 (71%) were mechanically ventilated. The overall incidence of pneumothorax was 85/842 (10%), and 80/594 (13%) in those who were mechanically ventilated. As compared to mechanically ventilated patients in the non-pneumothorax group, mechanically ventilated patients in the pneumothorax group had worse respiratory parameters at the time of intubation (mean PaO2:FiO2 ratio 105 vs 150, P<0.001 and static respiratory system compliance: 30ml/cmH2O vs 39ml/cmH2O, P = 0.01) and significantly higher in-hospital mortality (63% vs 49%, P = 0.04). CONCLUSION: The overall incidence of pneumothorax in mechanically ventilated patients with COVID-19 infection was 13%. Mechanically ventilated patients with COVID-19 infection who developed pneumothorax had worse gas exchange and respiratory mechanics at the time of intubation and had a higher mortality compared to those who did not develop pneumothorax.


Subject(s)
COVID-19/complications , Critical Illness , Pneumothorax/etiology , Respiration, Artificial/adverse effects , Adult , Aged , COVID-19/mortality , COVID-19/physiopathology , COVID-19/therapy , Case-Control Studies , Female , Hospital Mortality , Humans , Incidence , Male , Middle Aged , Multicenter Studies as Topic , Pneumothorax/epidemiology , Pneumothorax/mortality , Pneumothorax/physiopathology , Prognosis , Pulmonary Gas Exchange , Retrospective Studies , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL